Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inder Anand

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Journal of the American College of Cardiology|December 6, 2008
Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) ProgramPeter A Meredith, Jan Ostergren, Inder Anand, et al.
Journal of the American Heart Association|October 20, 2021
Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection FractionWan Ting Tay, Tiew-Hwa Katherine Teng, Oliver Simon, et al.
European Heart Journal|September 17, 2015
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fractionScott D Solomon, Brian Claggett, Eldrin F Lewis, et al.
Circulation|November 6, 2002
Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT)Roberto Latini, Serge Masson, Inder Anand, et al.
American Heart Journal|February 8, 2020
Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipientsKenneth C Bilchick, Yongfei Wang, Jeptha P Curtis, et al.
European Journal of Heart Failure|April 10, 2013
Asian Sudden Cardiac Death in Heart Failure (ASIAN-HF) registryCarolyn S P Lam, Inder Anand, Shu Zhang, et al.
Circulation. Cardiovascular Quality and Outcomes|December 9, 2022
Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF RegistryKanako Teramoto, Wan Ting Tay, Jasper Tromp, et al.
Circulation. Heart Failure|December 21, 2018
Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection FractionSenthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
Journal of the American Heart Association|August 22, 2019
Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection FractionJonathan Yap, Wan Ting Tay, Tiew-Hwa Katherine Teng, et al.
Journal of the American College of Cardiology|May 27, 2017
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-DefibrillatorsKenneth C Bilchick, Yongfei Wang, Alan Cheng, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Journal of the American College of Cardiology|December 6, 2008
Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) ProgramPeter A Meredith, Jan Ostergren, Inder Anand, et al.
Journal of the American Heart Association|October 20, 2021
Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection FractionWan Ting Tay, Tiew-Hwa Katherine Teng, Oliver Simon, et al.
European Heart Journal|September 17, 2015
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fractionScott D Solomon, Brian Claggett, Eldrin F Lewis, et al.
Circulation|November 6, 2002
Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT)Roberto Latini, Serge Masson, Inder Anand, et al.
American Heart Journal|February 8, 2020
Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipientsKenneth C Bilchick, Yongfei Wang, Jeptha P Curtis, et al.
European Journal of Heart Failure|April 10, 2013
Asian Sudden Cardiac Death in Heart Failure (ASIAN-HF) registryCarolyn S P Lam, Inder Anand, Shu Zhang, et al.
Circulation. Cardiovascular Quality and Outcomes|December 9, 2022
Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF RegistryKanako Teramoto, Wan Ting Tay, Jasper Tromp, et al.
Circulation. Heart Failure|December 21, 2018
Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection FractionSenthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
Journal of the American Heart Association|August 22, 2019
Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection FractionJonathan Yap, Wan Ting Tay, Tiew-Hwa Katherine Teng, et al.
Journal of the American College of Cardiology|May 27, 2017
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-DefibrillatorsKenneth C Bilchick, Yongfei Wang, Alan Cheng, et al.
Pageof 11